Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
So-Young InternationalSY -4.89%73 Debt-to-EBITDA is -1.64 as of Mar. 2026. GuruFocus rates SY with a GF Score™ of 73/100 and a GF Value™ of $1.51 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 478 Healthcare Providers & Services companies, So-Young International ranks worse than 209204.81% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for So-Young International's Debt-to-EBITDA or its related term are showing as below:
SY'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -9.75 Med: -1.43 Max: 1.67
Current: -1.39
During the past 10 years, the highest Debt-to-EBITDA Ratio of So-Young International was 1.67. The lowest was -9.75. And the median was -1.43.
SY's Debt-to-EBITDA is ranked worse than 100% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.25
vs SY: -1.39
So-Young International (NAS:SY) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
So-Young International Debt-to-EBITDA Related Terms
So-Young International Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for So-Young International's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, So-Young International's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
So-Young International Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, So-Young International's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where So-Young International's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
So-Young International (SY) has a Debt-to-EBITDA of -1.64 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on So-Young International. According to the industry distribution chart, So-Young International ranks #999999 out of 478 companies in the Healthcare Providers & Services industry.
Is So-Young International's Debt-to-EBITDA too high?
So-Young International's current Debt-to-EBITDA is -1.64. Based on the distribution chart, So-Young International ranks #999999 out of 478 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, So-Young International has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does So-Young International's Debt-to-EBITDA compare to HCAT and AMWL?
According to the Healthcare Providers & Services industry distribution chart, So-Young International ranks #999999 out of 478 companies for Debt-to-EBITDA. This places So-Young International in the lower half of its industry. The industry median Debt-to-EBITDA is 2.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.25, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on So-Young International. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. So-Young International's current Debt-to-EBITDA is -1.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is So-Young International stock overvalued right now?
Based on GuruFocus' analysis, So-Young International (SY) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.51, compared to a current price of $1.75 — trading 15.9% above its estimated fair value. The current Debt-to-EBITDA is -1.64. So-Young International's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For So-Young International (SY), the current Debt-to-EBITDA is -1.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is So-Young International (SY) Overvalued in 2026?
Based on GuruFocus' analysis, So-Young International stock appears to be overvalued.
The current stock price of $1.75 is trading 15.9% above its estimated GF Value™ of $1.51.
GuruFocus considers So-Young International to be Modestly Overvalued.
Key valuation signals for SY:
Debt-to-EBITDA: -1.64
GF Value™: $1.51 vs. price of $1.75 (15.9% above fair value)
No single metric tells the full story. See the SY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
So-Young International Inc is an aesthetic treatment platform in China connecting consumers with online services and offline treatments. Its online platform operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website, where both consumers and aesthetic practitioners can access media content, an engaging social community and a transparent reservation system. The company has four reportable segments: Aesthetic treatment services group, Platform service group, Wuhan Miracle, and Others. The majority of revenue is derived from the Platform service group, which generates revenue by providing information services and reservation services. All the company's revenues are derived from within the PRC.
73GF Score
Get the complete analysis for SY
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SY has been successfully added to your 
